Allurion Technologies (ALURD) Consolidated Net Income (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Consolidated Net Income came in at -$6.1 million in Q1 2026, down 306.06% YoY from $3.0 million in Q1 2025, and up 2.96% on a QoQ basis from -$6.3 million in Q4 2025.
Allurion Technologies (ALURD) Consolidated Net Income (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Consolidated Net Income data on file, last reported at -$6.1 million in Q1 2026.
- Quarterly Consolidated Net Income fell 306.06% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.6 million (down 206.61% YoY) and the FY2025 annual result came in at -$29.0 million, down 291.59% from the prior year.
- Consolidated Net Income grew to -$6.1 million in Q1 2026, from -$6.3 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $8.7 million in Q3 2024 to a low of -$22.0 million in Q2 2023.
- A 5-year average of -$9.8 million and a median of -$9.6 million in 2024 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2023 — Consolidated Net Income sank 306.96% — and 2024, when it jumped 140.25%.
- Tracing ALURD's Consolidated Net Income over 5 years: stood at -$13.0 million in 2022, then tumbled by 64.36% to -$21.4 million in 2023, then surged by 54.17% to -$9.8 million in 2024, then surged by 35.93% to -$6.3 million in 2025, then gained by 2.96% to -$6.1 million in 2026.
- The last three Consolidated Net Income figures came in at -$6.1 million (Q1 2026), -$6.3 million (Q4 2025), and -$11.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | -6.28 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -9.80 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | -13.01 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |